Press Releases

Displays all press releases

Trump meets with Zelenskyy in push for Ukraine peace plan

U.S. President Donald Trump looks at Ukrainian President Volodymyr Zelenskyy upon his arrival for meetings at Trump’s Mar-a-Lago club in Palm Beach, Florida, on Dec. 28, 2025. Jonathan Ernst | Reuters President Donald Trump on Sunday welcomed Ukrainian President Volodymyr Zelenskyy to his Mar-a-Lago resort and said that he had a “productive” call with Russian […]

Trump meets with Zelenskyy in push for Ukraine peace plan Read More »

Trump officials reject over 300,000 student loan borrower IDR applications

Mixmike | E+ | Getty Images Many student loan borrowers have hit a repayment obstacle: the U.S. Department of Education denied their application to switch into a new payment plan. The department rejected 327,955 borrower requests to be enrolled in an income-driven repayment plan in August alone, according to a Dec. 15 court filing. The

Trump officials reject over 300,000 student loan borrower IDR applications Read More »

Abortion pill mifepristone access steady under Trump, FDA review looms

Mifepristone and Misoprostol pills are pictured Wednesday, Oct. 3, 2018, in Skokie, Illinois. Erin Hooley | Chicago Tribune | Tribune News Service | Getty Images Just over a year since Donald Trump was elected president again, the $6.9 billion abortion pill industry is operating under the same federal rules he inherited from former President Joe

Abortion pill mifepristone access steady under Trump, FDA review looms Read More »

Eli Lilly cuts cash prices of Zepbound weight loss drug vials

Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the company and the Trump administration to make the medicine more accessible. The announcement also comes weeks after chief rival Novo Nordisk unveiled additional discounts

Eli Lilly cuts cash prices of Zepbound weight loss drug vials Read More »

Jim Cramer has faith in Danaher’s turnaround as life sciences comes back to life

Life sciences stocks are seeing a resurgence — and that’s good news for Danaher . Connecting the dots to better times ahead for the struggling portfolio name, Jim Cramer thinks the industry turnaround is best illustrated by looking at Agilent Technologies ‘ recovery from a post-Covid rut. Shares are up around 50% from their April

Jim Cramer has faith in Danaher’s turnaround as life sciences comes back to life Read More »

RFK Jr.’s vaccine panel defers vote on hepatitis B shot for babies

Health and Human Services Secretary Robert F. Kennedy Jr.’s hand-picked vaccine committee on Thursday deferred crucial votes on hepatitis B vaccines for babies until Friday, saying it will give members more time to review proposed language on the measure. One panel member, Dr. Cody Meissner, a professor of pediatrics at the Dartmouth Geisel School of

RFK Jr.’s vaccine panel defers vote on hepatitis B shot for babies Read More »

Scroll to Top